Investment
Features
FeesSafety
Academy
More
Pluang+

Solana's Stocklana hackathon ends with 604 projects competing for $126K in tokenized stock trading prizes.

Protocol Fundamentals
05 Oct 2026
Crypto Briefing
View Source
Bullish
Solana's Stocklana hackathon ends with 604 projects competing for $126K in tokenized stock trading prizes.

The Solana Foundation concluded its Stocklana hackathon with 604 project submissions competing for a $126,000 prize pool focused on tokenized stocks that trade 24/7 on blockchain. The event tested demand for around-the-clock trading tools and debuted Solana's new self-serve hackathon platform. Partners PreStocks, Tessera, and Meteora contributed $26,000 in side prizes, highlighting interest in tokenized pre-IPO shares and private equity. Winners will be announced around October 2, 2026, signaling growing investor access to traditionally hard-to-reach markets.

Solana's Stocklana hackathon attracted 604 project submissions competing for $126,000 in prizes, showcasing interest in tokenized stocks and 24/7 trading tools. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 06, 2026 03:02 WIB: out of 50 major cryptocurrencies, 24 rose and 25 fell. Among notable movers, ADA (Cardano) rose 5.48% to Rp4.754 with a typical hold time of 126 days, contrasting with AXS (Axie Infinity) which fell 5.81% to Rp23.139 and ONE (Harmony) down 4.00% to Rp41, both with longer hold times and a majority buy order activity on Pluang.

More News

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...

Company Fundamentals
Bullish
52 minutes ago
Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...

Analyst Insights
Bullish
1 hour ago
GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Market News
Bullish
2 hours ago
NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

BNP Paribas Exane raised NVIDIA's price target from $285 to $345 due to strong demand for its AI chips, signaling potential upside of about 45.6% from the current price. NVIDIA shares have gained about 25% in 2026, driven by growth in AI infrastructu...

Analyst Insights
Bullish
3 hours ago
OpenAI adds invisible watermark to AI-generated text in EU to comply with new AI rules

OpenAI adds invisible watermark to AI-generated text in EU to comply with new AI rules

OpenAI will introduce an invisible watermark in text generated by ChatGPT and Codex within the European Union to comply with the EU AI Act's transparency requirements effective from August 2. This watermark subtly alters word choices to create a dete...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App